You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

androgen independent prostate cancer

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer Trial (KN026, HB1801, Pertuzumab)

Not yet recruiting
  • First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
  • (no location specified)
Apr 20, 2023

Immunological Responses of COVID-19 Vaccination

Recruiting
  • Cancer; Chemotherapy
  • COVID antibody titers in the blood
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Feb 10, 2022

Hawthorn Red Combined Refractory Cancer Pain Trial (Hawthorn red pigment)

Not yet recruiting
  • Hawthorn Red Combined Refractory Cancer Pain
  • Hawthorn red pigment
  • (no location specified)
Sep 26, 2022

Axillary Web Syndrome Trial in Faisalabad (Stretching exercises, Soft tissue mobilization)

Recruiting
  • Axillary Web Syndrome
  • Stretching exercises
  • Soft tissue mobilization
  • Faisalābad, Punjab, Pakistan
    Allied Hosptal
Jul 14, 2022

Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

Active, not recruiting
  • Triple Negative Breast Neoplasms
  • Los Alamitos, California
  • +154 more
Jan 12, 2023

Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters

Not yet recruiting
  • Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT
  • Jerusalem, Israel
    Sharett institute, Hadassah University Hospital - Ein-Kerem
Jul 4, 2022

Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

Active, not recruiting
Has Results
  • Follicular Lymphoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 6, 2022

Variation in Cancer Centers' End-of-Life Quality

Active, not recruiting
  • Advanced Cancer
  • Observation of provider-patient interactions and interviews
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
May 26, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Oct 11, 2022

Breast Cancer, Colon Cancer Trial in Madrid (Education program on healthy habits, Habitual)

Not yet recruiting
  • Breast Cancer
  • Colon Cancer
  • Education program on healthy habits
  • Habitual
  • Madrid, Spain
    Hospital Universitario Infanta Leonor
Apr 3, 2023

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Patients With Advanced Metastatic Colorectal Cancer Trial in Wuhan (Tislelizumab plus Fruquintinib and SBRT)

Active, not recruiting
  • Patients With Advanced Metastatic Colorectal Cancer
  • Tislelizumab plus Fruquintinib and SBRT
  • Wuhan, Hubei, China
    Huazhong University of Science and Technology
Aug 15, 2022

Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine Combined With Venetoclax and ATRA group
  • Suzhou, China
    the First Affiliated Hospital of Soochow University
Dec 8, 2022

Studying Lymph Nodes in Patients With Stage II Colon Cancer

Active, not recruiting
  • Colorectal Cancer
  • RNA marker analysis of lymph node and primary tumors
  • +5 more
  • Santa Monica, California
  • +1 more
Mar 7, 2022

Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)

Active, not recruiting
  • Multiple Myeloma
  • CT-011
  • Dendritic Cell Fusion Vaccine
  • Boston, Massachusetts
  • +2 more
Sep 5, 2022

Lung Cancer Trial (Cadonilimab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
Mar 23, 2023

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +2 more
  • Birmingham, Alabama
  • +10 more
Jan 25, 2023

Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
    • Lille, France
    • +3 more
    Jan 25, 2023

    Tumors, Pancreatic Tumors Trial run by the NCI (LMB-100, Nab-Paclitaxel, Mesothelin Expression)

    Completed
    Has Results
    • Neoplasms
    • Pancreatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 16, 2022

    Molecular Services and EMR-Lab Integration Application for

    Not yet recruiting
    • Advanced Cancer
    • +2 more
    • Comprehensive Genomic Profile testing; ELIA software; Molecular Genetic Pathologist consultation
    • limited genetic testing or no testing
    • Rock Hill, South Carolina
      Carolina Blood and Cancer Care Associates
    Oct 18, 2023

    NSCLC Trial in Worldwide (X-396 (ensartinib), crizotinib)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Phoenix, Arizona
    • +122 more
    Oct 21, 2022

    Patients Receiving T-DXd for Treatment of HER2+ Unresectable

    Not yet recruiting
    • Breast Cancer
    • None (Observational Study)
    • (no location specified)
    Oct 20, 2022

    Breast Cancer Trial in New Haven (Everolimus)

    Terminated
    Has Results
    • Breast Cancer
    • New Haven, Connecticut
      Yale University
    Jan 12, 2022

    Neuropathic Pain Trial in Medellín (Repetitive transcranial magnetic stimulation)

    Recruiting
    • Neuropathic Pain
    • Repetitive transcranial magnetic stimulation
    • Medellín, Antioquia, Colombia
      CORTEX
    Jul 27, 2022

    Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

    Recruiting
    • Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Sep 15, 2022